8-K
filed June 7, 2023, 7:59 PM ET
ticker RCEL
CIK 0001762303
other
confidence high
sentiment neutral
materiality 0.40
AVITA Medical stockholders approve 2.5M share increase in 2020 Omnibus Plan and new ESPP
AVITA Medical, Inc.
- Stockholders approved amendment to 2020 Omnibus Incentive Plan increasing shares by 2.5 million.
- Stockholders approved Employee Stock Purchase Plan authorizing up to 1 million shares.
- All seven director nominees elected; Grant Thornton LLP ratified as auditor for FY 2023.
- Advisory vote on named executive officer compensation approved: ~8.6M for, ~1.6M against.
- CEO James Corbett granted options to acquire 100,000 shares; non-employee directors receive RSUs and options.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
AVITA Medical, Inc. shareholders approved Issuance of Securities to Mr. Louis Panaccio.
- Outcome
- passed
Exact text from the filing
3. Issuance of Securities to Mr. Louis Panaccio : Stockholders approved the grant of restricted stock units equal in value to $87,500 (at the time of the grant) and the grant of stock options equal in value to $37,500 (at the time of the grant) to Mr. Lou Panaccio on the terms and conditions set out in the Proxy Statement by a vote of (i) 8,895,435 in favor, (ii) 1,347,898 against, (iii) 765,723 abstaining, and (iv) 2,118,249 broker non-votes.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
AVITA Medical, Inc. shareholders approved Issuance of Securities to Mr. James Corbett.
- Outcome
- passed
Exact text from the filing
11. Issuance of Securities to Mr. James Corbett: Stockholders approved the grant of options to acquire 100,000 shares of common stock of the Company (which may be represented by CDIs) to the Company’s Chief Executive Officer, Mr. James Corbett, on the terms and conditions set forth in the Proxy Statement by a vote of (i) 8,618,300 in favor, (ii) 1,575,435 against, (iii) 815,321 abstaining, and (iv) 2,118,249 broker non-votes.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
AVITA Medical, Inc. shareholders approved Issuance of Securities to Mr. Cary Vance.
- Outcome
- passed
Exact text from the filing
9. Issuance of Securities to Mr. Cary Vance: Stockholders approved the grant of restricted stock units equal in value to $147,000 (at the time of the grant) and the grant of stock options equal in value to $63,000 (at the time of the grant) to Mr. Cary Vance on the terms and conditions set out in the Proxy Statement in recognition of Mr. Vance being appointed as a new director of the Company during 2023, by a vote of (i) 8,634,362 in favor, (ii) 1,546,936 against, (iii) 827,758 abstaining, and (iv) 2,118,249 broker non-votes.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
AVITA Medical, Inc. shareholders approved Issuance of Securities to Mr. Cary Vance.
- Outcome
- passed
Exact text from the filing
10. Issuance of Securities to Mr. Cary Vance: Stockholders approved the grant of restricted stock units equal in value to $87,500 (at the time of the grant) and the grant of stock options equal in value to $37,500 (at the time of the grant) to Mr. Cary Vance on the terms and conditions set out in the Proxy Statement by a vote of (i) 8,861,043 in favor, (ii) 1,361,352 against, (iii) 786,661 abstaining, and (iv) 2,118,249 broker non-votes.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
AVITA Medical, Inc. shareholders approved Appointment of Independent Auditor at the 2023-12-31 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-12-31
Exact text from the filing
2. Appointment of Independent Auditor . The appointment of Grant Thornton LLP as the Company’s independent public accountants for the fiscal year ending December 31, 2023 was ratified by a vote of (i) 12,509,340 in favor, (ii) 83,447 against, and (iii) 534,518 abstaining. The Company did not receive any broker non-votes with respect to such proposal.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
AVITA Medical, Inc. shareholders approved Amendment of 2020 Omnibus Plan.
- Proposal
- equity plan
- Outcome
- passed
Exact text from the filing
12. Amendment of 2020 Omnibus Plan: Stockholders approved (a) the Plan Amendment by a vote of (i) 8,918,961 in favor, (ii) 1,337,019 against, (iii) 753,076 abstaining, and (iv) 2,118,249 broker non-votes.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
AVITA Medical, Inc. shareholders approved Issuance of Securities to Professor Suzanne Crowe.
- Outcome
- passed
Exact text from the filing
4. Issuance of Securities to Professor Suzanne Crowe : Stockholders approved the grant of restricted stock units equal in value to $87,500 (at the time of the grant) and the grant of stock options equal in value to $37,500 (at the time of the grant) to Professor Suzanne Crowe on the terms and conditions set out in the Proxy Statement by a vote of (i) 8,931,133 in favor, (ii) 1,323,484 against, (iii) 754,439 abstaining, and (iv) 2,118,249 broker non-votes.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
AVITA Medical, Inc. shareholders approved Issuance of Securities to Mr. Jeremy Curnock Cook.
- Outcome
- passed
Exact text from the filing
5. Issuance of Securities to Mr. Jeremy Curnock Cook : Stockholders approved the grant of restricted stock units equal in value to $87,500 (at the time of the grant) and the grant of stock options equal in value to $37,500 (at the time of the grant) to Mr. Jeremy Curnock Cook on the terms and conditions set out in the Proxy Statement by a vote of (i) 8,877,076 in favor, (ii) 1,352,935 against, (iii) 779,045 abstaining, and (iv) 2,118,249 broker non-votes.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
AVITA Medical, Inc. shareholders approved Election of Directors.
- Proposal
- director election
- Outcome
- passed
Exact text from the filing
1. Election of Directors . All seven directors named in the Proxy Statement were elected to serve on the Company’s Board of Directors with the following vote: Name Votes For Votes Withheld Broker Non-Votes Louis Panaccio 9,435,124 1,573,932 2,118,249 James Corbett 10,042,656 966,400 2,118,249 Jeremy Curnock Cook 10,066,927 942,129 2,118,249 Professor Suzanne Crowe 10,173,257 835,799 2,118,249 Jan Stern Reed 9,785,570 1,223,486 2,118,249 Robert McNamara 10,205,699 803,357 2,118,249 Cary Vance 10,201,085 807,971 2,118,249
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
AVITA Medical, Inc. shareholders approved Issuance of Securities to Ms. Jan Stern Reed.
- Outcome
- passed
Exact text from the filing
6. Issuance of Securities to Ms. Jan Stern Reed : Stockholders approved the grant of restricted stock units equal in value to $87,500 (at the time of the grant) and the grant of stock options equal in value to $37,500 (at the time of the grant) to Ms. Jan Stern Reed on the terms and conditions set out in the Proxy Statement by a vote of (i) 8,895,165 in favor, (ii) 1,330,855 against, (iii) 783,036 abstaining, and (iv) 2,118,249 broker non-votes.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
AVITA Medical, Inc. shareholders approved Issuance of Securities to Mr. Robert McNamara.
- Outcome
- passed
Exact text from the filing
7. Issuance of Securities to Mr. Robert McNamara : Stockholders approved the grant of restricted stock units equal in value to $147,000 (at the time of the grant) and the grant of stock options equal in value to $63,000 (at the time of the grant) to Mr. Robert McNamara on the terms and conditions set out in the Proxy Statement in recognition of Mr. McNamara being appointed as a new director of the Company during 2023, by a vote of (i) 8,696,129 in favor, (ii) 1,507,847 against, (iii) 805,080 abstaining, and (iv) 2,118,249 broker non-votes.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
AVITA Medical, Inc. shareholders approved Issuance of Securities to Mr. Robert McNamara.
- Outcome
- passed
Exact text from the filing
8. Issuance of Securities to Mr. Robert McNamara: Stockholders approved the grant of restricted stock units equal in value to $87,500 (at the time of the grant) and the grant of stock options equal in value to $37,500 (at the time of the grant) to Mr. Robert McNamara on the terms and conditions set out in the Proxy Statement by a vote of (i) 8,881,317 in favor, (ii) 1,345,548 against, (iii) 782,191 abstaining, and (iv) 2,118,249 broker non-votes.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.